According to the new market research report by
IndustryARC titled “ Cancer
Testing and Screening Market: By
Techniques (Imaging, Biopsy,, Biomarkers); By Cancer Type (Respiratory, Breast,
Skin, Digestive),Stage, Gender, Product Type, Geography - Forecasts 2018 – 2023”
the market is expected to grow due to the rise in geriatric population and
unhealthy lifestyles.
Americas to have a major share in the Cancer
Testing and Screening Market
Americas will dominate the Cancer Testing and
Screening Market during the forecast period. Asia Pacific will have the highest
growth in the market due to increasing number of cancer affected people in the
region. In the US, Cancer is the second main cause of deaths. In men,
prostrate, lung, and colon accounted for 44% of the diagnosed cancers in 2016.
Prostate cancer represents 1 out of 5 cases. In women, three types of cancers
in 2016 were breast, lung, and colon. To curb such cancers, continuous
screening is needed. This will drive the growth of Cancer screening in US.
In Asia Pacific, increasing population and ageing
in China has resulted in the increasing incidences and mortality of cancer in
the region. This has compelled the government in the region to propose
demonstration projects. WHO proposed Program for Cancer prevention and control
in China, the program will provide cancer screening facilities.
Cancer Testing and Screening Market Analysis done
in the full Report:
Imaging techniques involves the process of
creating a visual representation of the interior of a body for clinical
analysis with regard to the functioning of the internal organs. This process
for diagnosis of cancer includes radiography, computed tomography, magnetic
resonance imaging, and endoscopy. Imaging tests such as CT scan and X rays
generate pictures of the body’s interior without the need for incision. They
provide information about the size, shape, and location of the problem.
Endoscopy plays an important role in identifying
the spread of cancer in the patient’s body. Various kinds of endoscopy include
endoscopic ultrasound, endoscopic retrograde, and cholangiopancreatography
(ERCP).
Talk to
one of our sales representative about the Cancer Testing and Screening Market report by providing your
details in the link below:
Excerpts on Cancer Testing and Screening Market Growth
Factors
- Growing demand for enhanced procedure accuracy during cancer
testing for avoiding the side effects has driven the need for advanced
technologies. This has driven the R&D investments in the Cancer
Testing and Screening Market.
- Testing and screening programs can reduce the burden of cancer by
ensuring people get the tests done in a timely manner.
- Improvements in Low Dose
Computed Tomography (LDCT) technology and minimally surgical techniques
makes the adoption of lung cancer screening stronger.
- Unhealthy lifestyles such
as lack of physical exercise and consumption of diets rich in fats,
sugars, and salts will raise the risk for cancer. This drives the growth
of the Cancer Testing and Screening Market.
To
access Cancer Testing and Screening
Market report, browse the link below:
Key players of the Cancer Testing and Screening
Market
F. Hoffmann-La Roche Ltd. (Roche Diagnostics),
Danaher, Johnson & Johnson, Abbott Diagnostics, Siemens Healthcare and
Beckton Dickinson are expected to be the dominant players of the cancer
molecular testing market.
F.Hoffmann-La Roche provides test service in
treating and diagnosing breast cancer. Danaher designs, manufactures, and
markets healthcare, environmental, and industrial equipment. Recently, Johnson
& Johnson acquired C-SATS, a Seattle startup that gives performance reviews
for surgeons. Abbot provides a broad range of medical devices, diagnostics, and
nutrition products.
Cancer Testing and Screening Market is segmented
as below
Growing number of awareness programs for cancer
screening drives the demand for Cancer Testing and Screening Market.
1. Introduction
2. Lung Cancer
3. Blood Cancer
4. Bone Cancer
5. Abdominal Cancer
6. Eye Cancer
7. Mouth Cancer
8. Breast (Women) Cancer
9. Others
B. Cancer Testing and Screening Market By
Technique
1. Introduction
2. Imaging Techniques
3. Bio Marker Tests
4. Endoscopy
5. Radiation Techniques
6. Others
C. Cancer Testing and Screening Market By
Treatment
1. Introduction
2. Surgery
3. Radiation
4. Hormone Therapy
5. Chemo Therapy
6. Gene Therapy
7. Others
D. Cancer Testing and Screening Market By Stage
1. Tnm Stages
2. Stages 0,1,2,3,4
3. Prognostic Factors
4. Other Staging Systems
E. Cancer Testing and Screening Market By Gender
1. Men
2. Women
F. Cancer Testing and Screening Market By
Geography(covers 14+ countries)
Companies
Citied / Interviewed IN Cancer Testing
and Screening Market
1. DIASORIN
S.P.A.
2. IMMUNODIAGNOSTIC
SYSTEMS HOLDINGS PLC
3. EPIGENOMICS
AG
4. QUEST
DIAGNOSTICS INC
5. HOFFMANN-LA
ROCHE LTD.
6. TARGET
DISCOVERY
7. POSITIVE
BIOSCIENCES
8. CELDARA
MEDICAL
9. VOLITIONRX
10. Company
10 +
Related Report:
A. Genomics
in Cancer Care Market
B. U.S.
Drug Testing Market
What can you expect from the report?
The Cancer Testing and Screening Market Report is
Prepared with the Main Agenda to Cover the following 20 points:
1. Market Size by Product Categories &
Application 11. Demand Analysis
(Revenue & Volume)
2. Market trends & Relevant Market Data 12. Country level Analysis
3. Manufacturer Landscape 13. Competitor Analysis
4. Distributor Landscape 14. Market Shares Analysis
5. Pricing Analysis 15. Value Chain Analysis
6. Top 10 End user Analysis 16. Supply Chain Analysis
7. Product Benchmarking 17. Strategic Analysis
8. Product Developments 18. Current & Future Market
Landscape Analysis
9. Mergers & Acquisition Analysis 19. Opportunity Analysis
10. Patent Analysis 20. Revenue and Volume Analysis
Frequently Asked Questions:
Q. Does IndustryARC publish country or
application based reports in Cancer Testing and Screening segment?
Response: Yes,
we do have separate reports as mentioned below:
1. Americas
Cancer Testing and Screening Market Report (2018-2023)
2. Europe Cancer
Testing and Screening Market Analysis (2018-2023)
3. Asia Pacific
Cancer Testing and Screening Market Size (2018-2023)
Q. Does IndustryARC provide customized reports
and charge additionally for limited customization?
Response: Yes,
we can customize the report by extracting data from our database of reports and
annual subscription databases. We can provide the following free customization:
1. Increase the level of data in application or
end user industry.
2. Increase the number of countries in geography
chapter.
3. Find out market shares for other smaller
companies or companies which are of interest to you.
4. Company profiles can be requested based on
your interest.
5. Patent analysis, pricing, product analysis,
product benchmarking, value and supply chain analysis can be requested for a
country or end use segment.
Any other custom requirements can be discussed
with our team, drop an e-mail to
sales@industryarc.com to discuss more about our consulting services.
To request for a proposal, provide your details
in the below link:
Media Contact:
Mr. Venkat Reddy
Sales Manager
Email 1: sales@industryarc.com
Contact Sales: +1-614-588-8538 (Ext-101)
No comments:
Post a Comment